Skip to main navigation
Skip to search
Skip to main content
Tel Aviv University Home
Update Request & User Guide (TAU staff only)
Home
Experts
Research units
Research output
Datasets
Prizes
Activities
Press/Media
Search by expertise, name or affiliation
Pterygium Surgery with Mitomycin C: How Much Sclera Should Be Left Bare?
Rahamim Avisar
*
,
Dov Weinberger
*
Corresponding author for this work
Clinical Departments
Rabin Medical Center Israel
Research output
:
Contribution to journal
›
Article
›
peer-review
15
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Pterygium Surgery with Mitomycin C: How Much Sclera Should Be Left Bare?'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Sclera
100%
Mitomycin C
100%
Pterygium Surgery
100%
Conjunctiva
83%
Recurrence Risk
33%
Cosmetic Outcome
33%
Limbus
33%
Pterygium
33%
High Risk
16%
Consecutive Patients
16%
Surgical Treatment
16%
Complication Risk
16%
Postoperative Complications
16%
Drug Toxicity
16%
Aesthetic Outcome
16%
Scleral
16%
Recurrent Pterygium
16%
Cosmetic Appearance
16%
Bare Sclera
16%
Scleral Melt
16%
Clinical Trial Design
16%
Medicine and Dentistry
Sclera
100%
Mitomycin
100%
Pterygium
100%
Recurrent Disease
57%
Cosmetics
42%
Corneal Limbus
28%
Population Research
14%
Postoperative Complication
14%
Drug Toxicity
14%
Pterygium Excision
14%